Chronic hepatitis B with flare due to co-infection of hepatitis delta virus during lamivudine therapy

被引：1

作者：

Joh, R

Hasegawa, K

Tokushige, K

Hashimoto, E

Torii, N

Yamashiro, T

Enomoto, N

Watanabe, M

Hayashi, N

机构：

[1] Tokyo Womens Med Univ, Inst Gastroenterol, Shinjuku Ku, Tokyo 1628666, Japan

[2] Tokyo Med & Dent Univ, Fac Med, Dept Gastroenterol, Tokyo 113, Japan

来源：

INTERNAL MEDICINE | 2003年 / 42卷 / 07期

关键词：

HBV; HDV; lamivudine;

D O I：

10.2169/internalmedicine.42.581

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In 1997, a 27-year-old homosexual man contracted acute hepatitis B that developed into chronic hepatitis. Because of repeated flares, administration of lamivudine was started in March 2002. Hepatitis B virus (HBV) DNA immediately decreased, but the serum level of alanine aminotransferase gradually increased. Drug-induced hepatitis due to lamivudine was excluded. It was suspected that the progression of liver damage was caused by hepatitis delta virus (HDV), because the patient was positive for both anti-HDV antibody and HDV RNA. Coinfection of HDV should be considered a possibility if liver injury is not improved by lamivudine therapy.

引用

收藏

页码：581 / 586

页数：6

相关论文

共 21 条

[1] SPONTANEOUS EXACERBATION OF DISEASE-ACTIVITY IN PATIENTS WITH CHRONIC DELTA-HEPATITIS INFECTION - THE ROLE OF HEPATITIS-B, HEPATITIS-C OR HEPATITIS-D [J].

ACKERMAN, Z ;

VALINLUCK, B ;

MCHUTCHISON, JG ;

REDEKER, AG ;

GOVINDARAJAN, S .

HEPATOLOGY, 1992, 16 (03) :625-629

[2] Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy [J].

Dienstag, JL ;

Schiff, ER ;

Mitchell, M ;

Casey, DE ;

Gitlin, N ;

Lissoos, T ;

Gelb, LD ;

Condreay, L ;

Crowther, L ;

Rubin, M ;

Brown, N .

HEPATOLOGY, 1999, 30 (04) :1082-1087

[3] LIVER-DISEASE ACTIVITY AND HEPATITIS-B VIRUS-REPLICATION IN CHRONIC DELTA-ANTIGEN-POSITIVE HEPATITIS-B VIRUS CARRIERS [J].

HADZIYANNIS, SJ ;

SHERMAN, M ;

LIEBERMAN, HM ;

SHAFRITZ, DA .

HEPATOLOGY, 1985, 5 (04) :544-547

[4] Living-related partial liver transplantation for decompensated hepatitis B without reactivation of hepatitis B in the following 30 months [J].

Hasegawa, K ;

Hashimoto, E ;

Kanai, N ;

Ogawa, M ;

Naritomi, T ;

Taniai, M ;

Takasaki, K ;

Hayashi, N .

JOURNAL OF GASTROENTEROLOGY, 2001, 36 (09) :637-642

[5] Lamivudine resistance in immunocompetent chronic hepatitis B - Incidence and patterns [J].

Honkoop, P ;

Niesters, HGM ;

deMan, RAM ;

Osterhaus, ADME ;

Schalm, SW .

JOURNAL OF HEPATOLOGY, 1997, 26 (06) :1393-1395

[6] Effects of mutations in the small envelope protein of hepatitis B virus on assembly and secretion of hepatitis delta virus [J].

Jenna, S ;

Sureau, C .

VIROLOGY, 1998, 251 (01) :176-186

[7] Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C [J].

Kobayashi, M ;

Arase, Y ;

Ikeda, K ;

Tsubota, A ;

Suzuki, Y ;

Saitoh, S ;

Kobayashi, M ;

Suzuki, F ;

Akuta, N ;

Someya, T ;

Matsuda, M ;

Sato, J ;

Kumada, H .

JOURNAL OF GASTROENTEROLOGY, 2002, 37 (01) :35-39

[8] Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy [J].

Lau, DTY ;

Kleiner, DE ;

Park, Y ;

Di Bisceglie, AM ;

Hoofnagle, JH .

GASTROENTEROLOGY, 1999, 117 (05) :1229-1233

[9] Lamivudine for chronic delta hepatitis [J].

Lau, DTY ;

Doo, E ;

Park, Y ;

Kleiner, DE ;

Schmid, P ;

Kuhns, MC ;

Hoofnagle, JH .

HEPATOLOGY, 1999, 30 (02) :546-549

[10]

LEON P, 1988, EUR J CLIN MICROBIOL, V7, P533